NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 123 filers reported holding NOVAVAX INC in Q3 2013. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $15,204,000 | -31.7% | 12,066,999 | +12.7% | 0.00% | -40.0% |
Q3 2016 | $22,266,000 | -69.8% | 10,704,775 | +5.4% | 0.01% | -68.8% |
Q2 2016 | $73,829,000 | +41.1% | 10,155,357 | +0.1% | 0.02% | +33.3% |
Q1 2016 | $52,340,000 | -37.5% | 10,143,371 | +1.7% | 0.01% | -36.8% |
Q4 2015 | $83,717,000 | +13.4% | 9,978,226 | -4.4% | 0.02% | 0.0% |
Q3 2015 | $73,796,000 | -33.3% | 10,437,968 | +5.1% | 0.02% | -29.6% |
Q2 2015 | $110,597,000 | +46.7% | 9,927,933 | +8.9% | 0.03% | +50.0% |
Q1 2015 | $75,403,000 | +42.7% | 9,117,614 | +2.3% | 0.02% | +38.5% |
Q4 2014 | $52,850,000 | +57.6% | 8,912,279 | +10.8% | 0.01% | +44.4% |
Q3 2014 | $33,541,000 | +2.4% | 8,043,390 | +13.5% | 0.01% | 0.0% |
Q2 2014 | $32,752,000 | -6.9% | 7,089,127 | -8.7% | 0.01% | -10.0% |
Q1 2014 | $35,168,000 | -8.0% | 7,763,431 | +4.0% | 0.01% | -16.7% |
Q4 2013 | $38,209,000 | +115.1% | 7,462,694 | +32.3% | 0.01% | +100.0% |
Q3 2013 | $17,764,000 | +81.5% | 5,639,238 | +18.1% | 0.01% | +50.0% |
Q2 2013 | $9,790,000 | – | 4,775,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |